Follow the people · Insider
Kevin James Craig
Kevin James Craig files insider transactions with the SEC as a chief medical officer of AtaiBeckley. We hold 3 disclosed purchases and sales filed since 6 March 2025, 1 of them in the last 90 days.
- Files forATAI
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure11 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 March 2025 — 11 September 2026Chief Medical Officer · AtaiBeckley 36 Form 4 lines · source: SEC Form 4
Every transaction
36 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckley | 8,437 shares | up +0.0% | up +0.0% |
| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckleyderivative | 10,000 shares | up +0.0% | up +0.0% |
| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckleyderivative | 50,400 shares | up +0.0% | up +0.0% |
| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckleyderivative | 28,608 shares | up +0.0% | up +0.0% |
| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckleyderivative | 372,701 shares | up +0.0% | up +0.0% |
| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckleyderivative | 673,808 shares | up +0.0% | up +0.0% |
| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckleyderivative | 675,000 shares | up +0.0% | up +0.0% |
| 11 Sep 2026 | 11 Sep 2026SEC Form 4 | 0 d | returned to the issuernot a trade | AtaiBeckleyderivative | 150,000 shares | up +0.0% | up +0.0% |
| 25 Jun 2026 | 29 Jun 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckley | 33,051 shares | up +60.5% | up +37.1% |
| 25 Jun 2026 | 29 Jun 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckley | 9,528 shares | up +60.5% | up +37.1% |
| 25 Jun 2026 | 29 Jun 2026SEC Form 4 | 4 d | sold on the open market | AtaiBeckley | 42,579 shares | up +60.5% | up +37.1% |
| 25 Jun 2026 | 29 Jun 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckleyderivative | 33,051 shares | up +60.5% | up +37.1% |
| 25 Jun 2026 | 29 Jun 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckleyderivative | 9,528 shares | up +60.5% | up +37.1% |
| 20 Apr 2026 | 22 Apr 2026SEC Form 4 | 2 d | exercised options overnot a trade | AtaiBeckley | 27,280 shares | up +50.0% | up +56.1% |
| 20 Apr 2026 | 22 Apr 2026SEC Form 4 | 2 d | exercised options overnot a trade | AtaiBeckley | 15,299 shares | up +50.0% | up +56.1% |
| 20 Apr 2026 | 22 Apr 2026SEC Form 4 | 2 d | sold on the open market | AtaiBeckley | 42,579 shares | up +50.0% | up +56.1% |
| 20 Apr 2026 | 22 Apr 2026SEC Form 4 | 2 d | exercised options overnot a trade | AtaiBeckleyderivative | 27,280 shares | up +50.0% | up +56.1% |
| 20 Apr 2026 | 22 Apr 2026SEC Form 4 | 2 d | exercised options overnot a trade | AtaiBeckleyderivative | 15,299 shares | up +50.0% | up +56.1% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckley | 76,224 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckley | 23,776 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | sold on the open market | AtaiBeckley | 100,000 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckleyderivative | 76,224 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckleyderivative | 23,776 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckleyderivative | 76,224 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckleyderivative | 23,776 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckley | 76,224 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | exercised options overnot a trade | AtaiBeckley | 23,776 shares | up +110.6% | up +117.5% |
| 20 Mar 2026 | 24 Mar 2026SEC Form 4 | 4 d | sold on the open market | AtaiBeckley | 100,000 shares | up +110.6% | up +117.5% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | was grantednot a trade | AtaiBeckleyderivative | 675,000 shares | up +95.5% | up +89.9% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | was grantednot a trade | AtaiBeckleyderivative | 150,000 shares | up +95.5% | up +89.9% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | was grantednot a trade | AtaiBeckleyderivative | 675,000 shares | up +95.5% | up +89.9% |
| 30 Jan 2026 | 3 Feb 2026SEC Form 4 | 4 d | was grantednot a trade | AtaiBeckleyderivative | 150,000 shares | up +95.5% | up +89.9% |
| 21 Mar 2025 | 24 Mar 2025SEC Form 4 | 3 d | sold on the open market | ATAI Life Sciences | 11,563 shares | up +406.9% | up +368.2% |
| 14 Mar 2025 | 19 Mar 2025SEC Form 4 | 5 d | exercised options overnot a trade | ATAI Life Sciencesderivative | 20,000 shares | up +396.6% | up +428.8% |
| 14 Mar 2025 | 19 Mar 2025SEC Form 4 | 5 d | exercised options overnot a trade | ATAI Life Sciences | 20,000 shares | up +396.6% | up +428.8% |
| 3 Mar 2025 | 6 Mar 2025SEC Form 4 | 3 d | was grantednot a trade | ATAI Life Sciencesderivative | 757,915 shares | up +390.0% | up +368.2% |
Both percentages are the stock’s move, not Kevin James Craig’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 36 of the 36 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.